Cargando…

Acetazolamide potentiates the afferent drive to prefrontal cortex in vivo

The knowledge on real‐time neurophysiological effects of acetazolamide is still far behind the wide clinical use of this drug. Acetazolamide – a carbonic anhydrase inhibitor – has been shown to affect the neuromuscular transmission, implying a pH‐mediated influence on the central synaptic transmissi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bueno‐Junior, Lezio S., Ruggiero, Rafael N., Rossignoli, Matheus T., Del Bel, Elaine A., Leite, Joao P., Uchitel, Osvaldo D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256155/
https://www.ncbi.nlm.nih.gov/pubmed/28087816
http://dx.doi.org/10.14814/phy2.13066
_version_ 1782498657754415104
author Bueno‐Junior, Lezio S.
Ruggiero, Rafael N.
Rossignoli, Matheus T.
Del Bel, Elaine A.
Leite, Joao P.
Uchitel, Osvaldo D.
author_facet Bueno‐Junior, Lezio S.
Ruggiero, Rafael N.
Rossignoli, Matheus T.
Del Bel, Elaine A.
Leite, Joao P.
Uchitel, Osvaldo D.
author_sort Bueno‐Junior, Lezio S.
collection PubMed
description The knowledge on real‐time neurophysiological effects of acetazolamide is still far behind the wide clinical use of this drug. Acetazolamide – a carbonic anhydrase inhibitor – has been shown to affect the neuromuscular transmission, implying a pH‐mediated influence on the central synaptic transmission. To start filling such a gap, we chose a central substrate: hippocampal‐prefrontal cortical projections; and a synaptic phenomenon: paired‐pulse facilitation (a form of synaptic plasticity) to probe this drug's effects on interareal brain communication in chronically implanted rats. We observed that systemic acetazolamide potentiates the hippocampal‐prefrontal paired‐pulse facilitation. In addition to this field electrophysiology data, we found that acetazolamide exerts a net inhibitory effect on prefrontal cortical single‐unit firing. We propose that systemic acetazolamide reduces the basal neuronal activity of the prefrontal cortex, whereas increasing the afferent drive it receives from the hippocampus. In addition to being relevant to the clinical and side effects of acetazolamide, these results suggest that exogenous pH regulation can have diverse impacts on afferent signaling across the neocortex.
format Online
Article
Text
id pubmed-5256155
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52561552017-01-26 Acetazolamide potentiates the afferent drive to prefrontal cortex in vivo Bueno‐Junior, Lezio S. Ruggiero, Rafael N. Rossignoli, Matheus T. Del Bel, Elaine A. Leite, Joao P. Uchitel, Osvaldo D. Physiol Rep Original Research The knowledge on real‐time neurophysiological effects of acetazolamide is still far behind the wide clinical use of this drug. Acetazolamide – a carbonic anhydrase inhibitor – has been shown to affect the neuromuscular transmission, implying a pH‐mediated influence on the central synaptic transmission. To start filling such a gap, we chose a central substrate: hippocampal‐prefrontal cortical projections; and a synaptic phenomenon: paired‐pulse facilitation (a form of synaptic plasticity) to probe this drug's effects on interareal brain communication in chronically implanted rats. We observed that systemic acetazolamide potentiates the hippocampal‐prefrontal paired‐pulse facilitation. In addition to this field electrophysiology data, we found that acetazolamide exerts a net inhibitory effect on prefrontal cortical single‐unit firing. We propose that systemic acetazolamide reduces the basal neuronal activity of the prefrontal cortex, whereas increasing the afferent drive it receives from the hippocampus. In addition to being relevant to the clinical and side effects of acetazolamide, these results suggest that exogenous pH regulation can have diverse impacts on afferent signaling across the neocortex. John Wiley and Sons Inc. 2017-01-13 /pmc/articles/PMC5256155/ /pubmed/28087816 http://dx.doi.org/10.14814/phy2.13066 Text en © 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Bueno‐Junior, Lezio S.
Ruggiero, Rafael N.
Rossignoli, Matheus T.
Del Bel, Elaine A.
Leite, Joao P.
Uchitel, Osvaldo D.
Acetazolamide potentiates the afferent drive to prefrontal cortex in vivo
title Acetazolamide potentiates the afferent drive to prefrontal cortex in vivo
title_full Acetazolamide potentiates the afferent drive to prefrontal cortex in vivo
title_fullStr Acetazolamide potentiates the afferent drive to prefrontal cortex in vivo
title_full_unstemmed Acetazolamide potentiates the afferent drive to prefrontal cortex in vivo
title_short Acetazolamide potentiates the afferent drive to prefrontal cortex in vivo
title_sort acetazolamide potentiates the afferent drive to prefrontal cortex in vivo
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256155/
https://www.ncbi.nlm.nih.gov/pubmed/28087816
http://dx.doi.org/10.14814/phy2.13066
work_keys_str_mv AT buenojuniorlezios acetazolamidepotentiatestheafferentdrivetoprefrontalcortexinvivo
AT ruggierorafaeln acetazolamidepotentiatestheafferentdrivetoprefrontalcortexinvivo
AT rossignolimatheust acetazolamidepotentiatestheafferentdrivetoprefrontalcortexinvivo
AT delbelelainea acetazolamidepotentiatestheafferentdrivetoprefrontalcortexinvivo
AT leitejoaop acetazolamidepotentiatestheafferentdrivetoprefrontalcortexinvivo
AT uchitelosvaldod acetazolamidepotentiatestheafferentdrivetoprefrontalcortexinvivo